Live from the NIH registry
Studies recruiting near Little Rock right now
Top 25 of 505 recruiting studies, sorted by proximity — each links to its official registry page
The Ailliance Post-Market Clinical Study
Spinal Deformity, Spinal Degenerative Disorder
N/A
Interventional 1,000 participants sought
OrthoArkansas — Little Rock, Arkansas (4.1 mi)
· Sponsor: Medtronic Spinal and Biologics
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Giselle Sholler
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
CARTI Cancer Center — Little Rock, Arkansas (4.1 mi)
· Sponsor: NRG Oncology
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
University of Arkansas — Little Rock, Arkansas (4.1 mi)
· Sponsor: Lyell Immunopharma, Inc.
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Cognitive Impairment Associated With Schizophrenia (CIAS)
Phase 2
Interventional 150 participants sought
Woodland International Research Group — Little Rock, Arkansas (4.1 mi)
· Sponsor: Kynexis B.V.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Medical Investigations — Little Rock, Arkansas (4.1 mi)
· Sponsor: Medtronic MiniMed, Inc.
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
Complex Congenital Heart Defect, Dysfunctional RVOT Conduit
N/A
Interventional 108 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Edwards Lifesciences
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
University of Arkansas Medical Center — Little Rock, Arkansas (4.1 mi)
· Sponsor: GT Medical Technologies, Inc.
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Schizophrenia, Bipolar I Disorder
Phase 3
Interventional 220 participants sought
Alkermes Investigator Site — Little Rock, Arkansas (4.1 mi)
· Sponsor: Alkermes, Inc.
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2, Phase 3
Interventional 786 participants sought
Alkermes Investigational Site — Little Rock, Arkansas (4.1 mi)
· Sponsor: Alkermes, Inc.
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
Peanut Allergy
Phase 2
Interventional 62 participants sought
Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology — Little Rock, Arkansas (4.1 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Tardive Dyskinesia
Phase 2
Interventional 100 participants sought
Neurocrine Clinical Site — Bryant, Arkansas (11.7 mi)
· Sponsor: Neurocrine Biosciences
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma
Phase 2
Interventional 90 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Carl Allen
SELUTION4BTK Trial
Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
N/A
Interventional 376 participants sought
Arkansas Heart Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: M.A. Med Alliance S.A.
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Applied Research Center of Arkansas — Little Rock, Arkansas (4.1 mi)
· Sponsor: Rejoni Inc.
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Preferred Research Partners /ID# 270389 — Little Rock, Arkansas (4.1 mi)
· Sponsor: AbbVie
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Arkansas Gastroenterology - North Little Rock — North Little Rock, Arkansas (6.0 mi)
· Sponsor: Ardelyx
Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer
Borderline Resectable/Unresectable Pancreatic Cancer, Non Metastatic Pancreatic Cancer
Phase 1, Phase 2
Interventional 20 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: University of Arkansas
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Arkansas Clinical Research — Little Rock, Arkansas (4.1 mi)
· Sponsor: TriGemX Bio, Inc.
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Children's Oncology Group
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Novartis Pharmaceuticals
Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy
Endocervical Cancer
N/A
Interventional 20 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: University of Arkansas
Encore PFO Closure Device - The PerFOrm Trial
Patent Foramen Ovale, Cryptogenic Stroke
N/A
Interventional 500 participants sought
Arkansas Cardiology — Little Rock, Arkansas (4.1 mi)
· Sponsor: Encore Medical Inc.
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: National Cancer Institute (NCI)
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
Benign Prostatic Hyperplasia
N/A
Interventional 92 participants sought
Arkansas Urology — Little Rock, Arkansas (4.1 mi)
· Sponsor: Urotronic Inc.